P

Inventor

DIJKE PETER TEN

NL11 patents
⚠️ This page may combine multiple inventors who share the name “DIJKE PETER TEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LUDWIG INST CANCER RES

6 patents
US6692925B1Feb 17, 2004

Proteins having serine/threonine kinase domains, corresponding nucleic acid molecules, and their use

LUDWIG INST CANCER RES110 citations95
US6251628B1Jun 26, 2001

Isolated nucleic acid molecules encoding Smad7

LUDWIG INST CANCER RES31 citations91
US6103869AAug 15, 2000

Smad2 phosphorylation and interaction with Smad4

LUDWIG INST CANCER RES11 citations70
US6673570B1Jan 6, 2004

Smad associating polypeptides

LUDWIG INST CANCER RES3 citations58
US8012704B2Sep 6, 2011

Proteins having serine/threonine kinase domains, corresponding nucleic acid molecules, and their use

LUDWIG INST CANCER RES1 citations49
US6368829B1Apr 9, 2002

Smad2 phosphorylation and interaction with Smad4

LUDWIG INST CANCER RES1 citations48

CURIS INC

2 patents
US7067260B2Jun 27, 2006

Methods of identifying morphogen receptor-binding analogs

CURIS INC4 citations62
US6632618B1Oct 14, 2003

Morphogenic protein-specific cell surface receptors and uses therefor

CURIS INC4 citations62

CREATIVE BIOMOLECULES INC

1 patent
US5863738AJan 26, 1999

Methods of antagonizing OP-1 binding to a cell surface receptor utilizing ALK polypeptides

CREATIVE BIOMOLECULES INC39 citations96

ONCOGENE SCIENCE INC

1 patent
US5824297AOct 20, 1998

Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof

ONCOGENE SCIENCE INC25 citations92

O S I PHARMACEUTICALS INC

1 patent
US5871724AFeb 16, 1999

Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof

O S I PHARMACEUTICALS INC10 citations68